Finance
Can-Fite stock jumps 18% on pancreatic cancer trial data
Can-Fite stock jumps 18% on pancreatic cancer trial data
I
Investing.com
April 30, 2026·1 min read
GM
FinanceCan-Fite stock jumps 18% on pancreatic cancer trial data
Original article
Can-Fite stock jumps 18% on pancreatic cancer trial data
Published by Investing.com